Sign Up Today and Learn More About Intarcia Therapeutics Stock
Invest in or calculate the value of your shares in Intarcia Therapeutics or other pre-IPO companies through EquityZen's platform.
Intarcia Therapeutics Stock
Intarcia Therapeutics is a biopharmaceutical company developing therapies for diseases that require long-term chronic treatment.
About Intarcia Therapeutics Stock
Founded
1997
Total Funding
1.1B
Industries
Software, Artificial Intelligence, Data and Analytics
Intarcia Therapeutics, Inc. is a biopharmaceutical company that develops therapies for diseases that require long-term chronic treatment. It offers DUROS, a drug delivery platform that stabilizes and delivers therapeutic proteins and peptides. The company's products include OMEGA DUROS, an interferon delivery device for treating Hepatitis C and ITCA 650, a delivery device that provides type 2 diabetes patients with long-term steady state dosing of an incretin mimetic therapy. Additionally, it develops programs for treating obesity. The company was formerly known as BioMedicines, Inc. and changed its name to Intarcia Therapeutics, Inc. in September 2004. Intarcia Therapeutics was founded in 1997 and is based in Hayward, California with an additional office in Mountain View, California.
Intarcia Therapeutics Press Mentions
Stay in the know about the latest news on Intarcia Therapeutics
Intarcia Therapeutics Takes One Last Shot at FDA Approval
wsj • Nov 22, 2021
After repeated FDA rejections, key investor writes down stake in former diabetes unicorn Intarcia Therapeutics
statnews • Jan 13, 2021
Unicorn startup companies 2020: List of top 500 unicorn startups with valuation of $1 Billion+
techstartups • Nov 20, 2020
Intarcia Therapeutics takes another run at FDA approval
massdevice • Oct 16, 2019
Numab Announces Entry into a License Agreement With Intarcia for Anti-Inflammatory ND016
businesswire • Mar 07, 2019
Investors in Intarcia Therapeutics
Discover investors in Intarcia Therapeutics stock and explore their portfolio companies
Intarcia Therapeutics Management
Leadership team at Intarcia Therapeutics
CFO & Vice President, Finance and Operations
James M. Ahlers
Vice President, Global Regulatory Affairs and Quality
Sunita Zalani
Join now and verify your accreditation status to gain access to:
- Intarcia Therapeutics current valuation
- Intarcia Therapeutics stock price
- Available deals in Intarcia Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
Trading Intarcia Therapeutics Stock
How to invest in Intarcia Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Intarcia Therapeutics through EquityZen funds. These investments are made available by existing Intarcia Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Intarcia Therapeutics stock?
Shareholders can sell their Intarcia Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 340K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 44K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
